ImmunoPrecise Antibodies Price to Book Ratio 2022-2025 | IPA

Historical price to book ratio values for ImmunoPrecise Antibodies (IPA) over the last 10 years. The current price to book ratio for ImmunoPrecise Antibodies as of April 22, 2025 is 0.77.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

ImmunoPrecise Antibodies Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2025-04-22 0.44 1.13
2025-01-31 0.47 $0.39 1.20
2024-10-31 0.48 $0.79 0.60
2024-07-31 0.79 $0.88 0.90
2024-04-30 1.28 $0.93 1.37
2024-01-31 1.81 $1.40 1.29
2023-10-31 2.30 $1.53 1.51
2023-07-31 2.52 $1.61 1.56
2023-04-30 2.57 $1.74 1.48
2023-01-31 4.40 $1.82 2.42
2022-10-31 4.97 $1.86 2.67
2022-07-31 4.23 $2.07 2.04
2022-04-30 5.56 $2.45 2.27
2022-01-31 6.18 $1.93 3.20
2021-10-31 6.57 $2.09 3.14
2021-07-31 6.58 $2.34 2.81
2021-04-30 9.76 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.014B $0.018B
ImmunoPrecise Antibodies Ltd. is a technology platform company with end-to-end solutions empowering companies to discover and develop therapies against any disease. ImmunoPrecise Antibodies Ltd. is based in VICTORIA.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $35.134B 48.53
Tempus AI (TEM) United States $6.966B 0.00
Hims & Hers Health (HIMS) United States $6.050B 97.25
Inspire Medical Systems (INSP) United States $4.470B 86.83
IRhythm Technologies (IRTC) United States $3.223B 0.00
Privia Health (PRVA) United States $2.873B 215.27
Schrodinger (SDGR) United States $1.881B 0.00
Clover Health Investments (CLOV) United States $1.839B 0.00
Enovis (ENOV) United States $1.825B 11.29
Omnicell (OMCL) United States $1.418B 30.59
Phreesia (PHR) United States $1.409B 0.00
Azenta (AZTA) United States $1.154B 53.72
10x Genomics (TXG) United States $0.918B 0.00
Butterfly Network (BFLY) United States $0.568B 0.00
Fulgent Genetics (FLGT) United States $0.551B 0.00
Talkspace (TALK) United States $0.450B 267.00
Veradigm (MDRX) United States $0.449B 0.00
Standard BioTools (LAB) United States $0.440B 0.00
TruBridge (TBRG) United States $0.363B 0.00
Claritev (CTEV) United States $0.325B 0.00
Health Catalyst (HCAT) United States $0.270B 0.00
Nyxoah SA (NYXH) Belgium $0.206B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.189B 0.00
Pulmonx (LUNG) United States $0.182B 0.00
American Well (AMWL) United States $0.109B 0.00
EUDA Health Holdings (EUDA) Singapore $0.100B 0.00
Retrieve Medical Holdings (RMHI) United States $0.082B 0.00
MDxHealth SA (MDXH) Belgium $0.076B 0.00
P3 Health Partners (PIII) United States $0.066B 0.00
111 (YI) China $0.064B 0.00
CareCloud (CCLD) United States $0.060B 2.58
HeartBeam (BEAT) United States $0.055B 0.00
Outset Medical (OM) United States $0.040B 0.00
Zepp Health (ZEPP) China $0.039B 0.00
Zhongchao (ZCMD) China $0.030B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Streamline Health Solutions (STRM) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Precipio (PRPO) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Syra Health (SYRA) United States $0.001B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00